Vivani Medical (VANI) Change in Accured Expenses (2014 - 2026)
Vivani Medical (VANI) posted quarterly Change in Accured Expenses of -$125000.0 for Q1 2026, down 1885.71% year-over-year from $7000.0 in Q1 2025, and down 35.87% quarter-over-quarter from -$92000.0 in Q4 2025.
Vivani Medical (VANI) Change in Accured Expenses (2014 - 2026) Analysis & Trends
Vivani Medical's Change in Accured Expenses history runs 13 years deep, the most recent figure standing at -$125000.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 1885.71% year-over-year to -$125000.0; the TTM figure through Mar 2026 stood at -$210000.0 (down 34.62% YoY), while the FY2025 annual figure was -$78000.0, down 47.17% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$125000.0, down from -$92000.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $167000.0 in Q1 2022, with the low at -$712000.0 in Q4 2023.
- The 5-year median for Change in Accured Expenses is $6000.0 (2025), against an average of -$43882.4.
- The sharpest annual moves came in 2022 and 2026: Change in Accured Expenses soared 542.31% in 2022, then tumbled 1885.71% in 2026.
- Vivani Medical's Change in Accured Expenses stood at -$128000.0 in 2022, then plunged by 456.25% to -$712000.0 in 2023, then soared by 110.96% to $78000.0 in 2024, then plunged by 217.95% to -$92000.0 in 2025, then sank by 35.87% to -$125000.0 in 2026.
- Business Quant data shows VANI's Change in Accured Expenses at -$125000.0 in Q1 2026, -$92000.0 in Q4 2025, and $1000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 212.44 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 61.62 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 68.82 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | 566,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 566,000.00 |
| Jun 30, 2026 | 566,000.00 |
| Mar 31, 2026 | -125,000.00 |
| Mar 31, 2026 | -125,000.00 |
| Dec 31, 2025 | -92,000.00 |
| Dec 31, 2025 | -92,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 78,000.00 |
| Dec 31, 2024 | 78,000.00 |
| Sep 30, 2024 | -119,000.00 |
| Sep 30, 2024 | -119,000.00 |
| Jun 30, 2024 | -122,000.00 |
| Jun 30, 2024 | -122,000.00 |
| Mar 31, 2024 | 110,000.00 |
| Mar 31, 2024 | 110,000.00 |